# Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company, Manati, PR – FDA Inspections

Source: https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968

> Inspection records and compliance data for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company in Manati, Puerto Rico. 14 FDA inspections on record (2 OAI), 4 Form 483s, last inspected February 13, 2026.

---

## Details

- Name: Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
- FEI Number: 2650089
- Address Line 1: Rd # 686, Km # 2.3, Sector Cotto Norte, Bo. Tierras Nuevas
- City: Manati
- State: Puerto Rico
- Zip Code: 00674
- Country Name: United States
- Address: Rd # 686, Km # 2.3, Sector Cotto Norte, Bo. Tierras Nuevas, Manati, Puerto Rico 00674, United States
- Country: United States

## Related Documents

- [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2026-02-13](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/473e5d65-fa74-4039-931e-190b8cca243e) — source: FDA, date: February 13, 2026
- [FDA Inspection 1305236 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2026-02-13](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/d4edb78e-8539-4958-aa1f-3f9b7c722066) — source: FDA, date: February 13, 2026
- [FDA Inspection 1242629 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2024-06-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/05545f68-893b-4e52-95ad-633611824057) — source: FDA, date: June 6, 2024
- [EIR - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12](https://www.keypedia.com/records/eir/bristol-myers-squibb-holdings-pharma-ltd-liability-company/56eb7270-8288-4e2e-9fa8-6dc4172554f0) — source: FDA, date: July 12, 2021
- 483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12 — source: FDA, date: July 12, 2021
- FDA Inspection 1147009 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2021
- [FDA Inspection 1147009 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2021-07-12](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/9fcd9e71-f132-4105-8b68-5dc2df75c023) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2021
- [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2019-11-19](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/1a7ca172-8509-4f22-b87f-30ac950c30a1) — source: FDA, date: November 19, 2019
- [FDA Inspection 1110480 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2019-11-19](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/95d01da7-6768-4d14-9aa2-0bc74e7edaf0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 19, 2019
- [FDA Inspection 1079769 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2019-02-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/723ebad3-1d56-4593-b123-69622c15f890) — classification: Official Action Indicated (OAI), source: FDA, date: February 6, 2019
- [483 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2017-09-11](https://www.keypedia.com/records/483/bristol-myers-squibb-holdings-pharma-ltd-liability-company/8e009935-5ba5-495d-8aa2-4f8de0e2e8ae) — source: FDA, date: September 11, 2017
- [FDA Inspection 1030016 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2017-09-11](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/1650c515-0cbd-4eb9-82f5-f588c5791f89) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2017
- FDA Inspection 986929 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2016-05-18 — classification: No Action Indicated (NAI), source: FDA, date: May 18, 2016
- FDA Inspection 949087 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2015-11-17 — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2015
- [FDA Inspection 949087 - Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company - 2015-11-17](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-holdings-pharma-ltd-liability-company/6640594c-8ea1-4706-81b7-185a5fb2d88e) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2015

## Related Companies

- [Liebel-Flarsheim Company LLC](https://www.keypedia.com/companies/liebel-flarsheim-company-llc/ca074473-a6a3-413d-828a-bee4671e7f97)
- [Tom's of Maine, Inc.](https://www.keypedia.com/companies/toms-of-maine-inc/4b3b44e0-d661-40b1-b271-61a8f81eccf7)
- [Sanofi S.r.l.](https://www.keypedia.com/companies/sanofi-srl/54ba861a-36eb-4486-a4ba-2a8194cdf7a5)
- [Alliance Medical Products, Inc. DBA Siegfried Company](https://www.keypedia.com/companies/alliance-medical-products-inc-dba-siegfried-company/3daf2f25-e22a-41c0-bcd9-d0f8ef1ab602)
- [Rechon Life Science AB](https://www.keypedia.com/companies/rechon-life-science-ab/ce84eed4-ada6-40a0-9005-2c2d6bbd729d)
- [Summit Biosciences Inc.](https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976)
- [Colgate-Palmolive Company](https://www.keypedia.com/companies/colgate-palmolive-company/7db665f6-094f-4de5-bf3b-c2528e2a223b)
- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/b85a1aa5-9a0c-4c1e-996d-70b40b2507de)
- [Ferndale Laboratories, Inc.](https://www.keypedia.com/companies/ferndale-laboratories-inc/0c6013f2-a6e7-41ff-a461-1e3fda056678)
- [Celltrion Pharm, Inc.](https://www.keypedia.com/companies/celltrion-pharm-inc/481a4273-bf7e-4b37-8cd8-08b977ba576b)

## Related Officers

- [Libia Lugo](https://www.keypedia.com/people/libia-lugo/55f1387e-b6bd-41ca-8507-45829629dac5)
- [Investigator](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f)
- [Investigator](https://www.keypedia.com/people/regina-t-brown/6e2de1b6-3e5d-40ec-8823-7f0aef908b2b)
- [Adaliz Santaliz-Cruz](https://www.keypedia.com/people/adaliz-santaliz-cruz/47bd4220-e6cc-4582-a4f5-bd4337f92622)
